baber/WOPTO huggingface dataset:
Patent NZ-608362-A (NZ)
Title: Adsorption of immunopotentiators to insoluble metal salts
Inventor: SINGH MANMOHAN
IPC: C07F9/40
Filed: 2011-09-01
Abstract: Disclosed are 4-amino-2-oxo-1-benzyl-2,3-dihydro-1H-imidazo[4,5-c]pyridine derivatives of the general formula (C) which are substituted with alkylphosphonic acid groups as TLR7 agonists for attachment to insoluble metal salts and for raising an immune response in the treatment of a viral disease, a bacterial disease, a fungal disease, and/or a parasitic disease; wherein: Xc is CH; P3 is selected from H, alkyl, trifluoromethyl, and H-((CH2)pO)q(CH2)pOs- and -Y-L-X-P(O)(ORx)(ORy); P4 is selected from H, alkyl, alkylaryl and -Y-L-X-P(O)(ORx)(ORy); Rx and Ry are independently selected from H and alkyl; Rc is selected from H and alkyl; X is selected from a covalent bond, O and NH; Y is selected from a covalent bond, O, C(=O), S and NH; L is selected from, a covalent bond, alkylene, alkenylene, arylene, heteroarylene, alkyleneoxy and -((CH2)pO)q(CH2)p- each optionally substituted with 1 to 4 substituents independently selected from halo, OH, alkyl, -OP(O)(OH)2 and P(O)(OH)2; p is 1-6; q is 1-4; and s is selected from 0 and 1; with the proviso that at least one of P3 and P4 is -Y-L-X-P(O)(ORx)(ORy). Representative compounds are selected from (4-(4-((4-amino-6-(2-methoxyethoxy)-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-1-yl)methyl)phenoxy)butyl)phosphonic acid, (4-(4-((4-amino-2-oxo-6-(trifluoromethyl)-2,3-dihydro-1H-imidazo[4,5-c]pyridin-1-yl)methyl)phenoxy)butyl)phosphonic acid, (3-((4-amino-1-(4-(butyloxyphosphonate)benzyl)-2-oxo-2,3-dihydro-1Himidazo[4,5-c]pyridin-6-yl)amino)propyl)phosphonic acid, (3-((4-amino-1-benzyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-6-yl)thio)propyl) phosphonic acid and (4-((4-amino-6-(2-methoxyethoxy)-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-1-yl)methyl)benzyl)phosphonic acid. Also disclosed is a composition comprising: (i) a TLR7 agonist as defined above and; (ii) an insoluble metal salt, for treating or preventing a viral disease, a bacterial disease, a fungal disease, and/or a parasitic disease.
Patent NZ-612090-A (NZ)
Title: Reduced ceramic heating element
Inventor: PLOJOUX JULIEN
IPC: H05K13/00
Filed: 2011-12-21
Abstract: An electrical heating element for electrical aerosol generating system is disclosed. It comprises a main body (10) which include a ceramic material and an electrically conductive layer (18) on the surface of the main body comprising a reduced form of the ceramic material. The electrically conductive layer has first and second contact portions (20, 22) for connection to a voltage source and at least one electrically conductive pathway between the first and second contact portions. To form the electrically conductive layer the heating element main body (10) is placed in a reducing environment at sufficient temperature to form the conductive layer (18) on the surface of the main body.
Patent NZ-617114-A (NZ)
Title: Apparatus and methods for tar removal from syngas
Inventor: KO CHING-WHAN
IPC: C10K3/00
Filed: 2012-04-04
Abstract: 617114 A process and apparatus are provided for reducing content of tar in a tar containing syngas (150). The process includes contacting the tar containing syngas with a molecular oxygen containing gas (250) in a first reaction zone (200) to produce a gas mixture. The gas mixture is passed through a heat treatment zone (300) maintained at a temperature between about 900°C to about 2000°C for a contact time of about 0.5 to about 5 seconds. In this aspect, at least a portion of the tar undergoes at least partial oxidation and/or cracking to produce a hot syngas (450).
Patent NZ-627778-A (NZ)
Title: Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
Inventor: MCVICAR WILLIAM K
IPC: C07H19/167
Filed: 2013-01-25
Abstract: Disclosed are anhydrous polymorph forms of (2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) methyl nitrate (Compound A). The compounds are selective adenosine A1 receptor agonists for use in the treatment of elevated intra-ocular pressure.
Patent NZ-629010-A (NZ)
Title: Inhalation device, control method and computer program
Inventor: GUMASTE ANAND V
IPC: G01F1/684
Filed: 2014-03-12
Abstract: Disclosed is an inhalation device for delivering medication from a container through a flow channel to a patient. The inhalation device comprises: an electrically driven vibratory element; a controller for activating/deactivating the vibratory element; a blister-advance mechanism and a sensor arrangement system. The sensor arrangement system comprises a first sensor physically arranged to face inhalation air to generate an inhalation flow signal and a second sensor physically arranged to face exhalation air to generate an exhalation flow signal. The controller is adapted to process the inhalation flow signal and exhalation flow signal to generate a trigger signal for controlling the timing of operation of the vibratory element. The controller is also adapted to generate a trigger signal for the blister advance mechanism.
Patent NZ-629632-A (NZ)
Title: A die or punch for a press tool
Inventor: ROBERT IAN BROADHEAD
IPC: B21D22/02
Filed: 2014-08-28
Abstract: A die or punch 2 for a press tool comprises a body, and a roller bearing 7 having a holder 9 and a roller 8. The holder 9 has at least one fastening groove 7a in a side that is adapted to engage with a complimentary protrusion in the body 6 in order to facilitate secure installation of the holder 9 in the body 6. The holder 9 is able to be removably inserted into the body 6 to present the roller 8 as a forming edge to shape a work piece 4 in a press tool. The roller 8 is able to turn with respect to the holder 9 when shaping the work piece 4 to protect the roller 8 against wear
Patent NZ-631279-A (NZ)
Title: Method for treatment of labor arrest
Inventor: EKMAN-ORDEBERG GUNVOR
IPC: A61K38/095
Filed: 2013-03-25
Abstract: Disclosed are chemically modified heparin or heparan sulfate compounds of formula (I) for use in combination with an agent capable of promoting myometrial contractions of the uterus (e.g., oxytocin) in the treatment of labour arrest (re-establishing effective labour in women when labour arrests). The compounds modification results in reduced anticoagulant activity with an antifactor lIa activity of less than 10 IU/mg and an antifactor Xa activity of less than 10 IU/mg.
Patent NZ-702826-A (NZ)
Title: Oral formulations and lipophilic salts of methylnaltrexone
Inventor: DIORIO CHRISTOPHER RICHARD
IPC: C07D471/00
Filed: 2011-03-10
Abstract: Disclosed is a salt of a compound of formula (I) where the anion A- is an amphiphilic pharmaceutically acceptable excipient. Also disclosed are compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration. The compounds and compositions are suitable for reducing side effects of opioid therapy.
Patent NZ-704160-A (NZ)
Title: Azaindole derivatives which act as pi3k inhibitors
Inventor: CHANG EDCON
IPC: C07D519/00
Filed: 2013-07-08
Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating immunological disorders, cardiovascular disease, cancer, and other diseases, disorders or conditions associated with PI3Kδ.
Patent NZ-711320-A (NZ)
Title: Credential management system
Inventor: NEAFSEY JEFFREY S
IPC: H04L9/00
Filed: 2013-02-13
Abstract: Disclosed is a system including a reader device configured to actuate a lock when presented with a registered user credential and a server that transmits an encapsulated virtual credential in a package to the mobile device wherein the virtual credential is of a particular form with at least two different formats. The at least two different formats include prox, MIFARE classic, MIFARE DESFire EV1, optical bar code and QR code and at least one of the formats includes either MIFARE classic or MIFARE DESFire EV1. An administrative mobile device with a credential administration application receives the virtual credential including a master credential and a plurality of user credentials for other users and wirelessly transmit the master credential to the reader device to place the reader device in a programming mode. The master credential is an administrative credential and the programming mode includes a construction mode that allows the plurality of user credentials to be stored in the reader device for future use. The administrative mobile device wirelessly transmits the plurality of user credentials to the reader device when the reader device is in the programming mode to register the plurality of user credentials in the reader device. The master credential is emulated on the administrative mobile device before each of an associated one of the plurality of user credentials is emulated on the administrative mobile device to register the each of the associated ones of the plurality of user credentials for the other users in the reader device.
Patent NZ-713855-A (NZ)
Title: Method for feeding electric power into an electric power supply system
Inventor: BEEKMANN ALFRED
IPC: H02P9/04
Filed: 2014-04-29
Abstract: The invention relates to a method for feeding electric power from at least one wind energy installation (100) or a wind farm (112) into an electric power supply system (120) at a mains voltage (U) and a mains frequency (F), wherein the method is prepared for feeding in electric active power (P) and electric reactive power (Q), and the active power (P) that is fed in can be set by means of an active power controller (R1, R2) on the basis of a system state (U, f) and/or the reactive power (Q) that is fed in can be set by means of a reactive power controller on the basis of at least one system state (U, f) and the active power controller (R1, R2) and the reactive power controller prescribe a setpoint value that is to be fed in that is set in each case by means of a setting function (Fs) on the basis of at least one system state (U, f), wherein the setting function (Fs) is prescribed by using sampling points (ST1, ST2, ST3) that are defined by pairs of values ([Pi, fi]) comprising, in each case, a value for the active power (P) or reactive power (Q) and a value for the system state (U, f).
Patent NZ-721067-A (NZ)
Title: Soilless plant cultivating container
Inventor: PIETER GIDEO VAN DER MERWE
IPC: A01G31/02
Filed: 2015-04-24
Abstract: The present disclosure is directed to cultivating plants without using soil, where the plants are exposed to a supply of nutrient containing fluid. Disclosed is a soilless plant cultivating container which includes an elongate body of generally wave shaped form having a flow channel defined therethrough, and at least one receptacle defined in a sidewall of the body in fluid communication with the flow channel for receiving and supporting a plant therein. The elongate body also includes an air passage arranged separate from the flow channel and extending longitudinally therealong, the air passage being in fluid communication with the receptacle for introducing temperature and oxygen regulated air to the receptacle.
Patent NZ-726623-A (NZ)
Title: Improved peptide pharmaceuticals for insulin resistance
Inventor: NESTOR JOHN
IPC: C07K14/605
Filed: 2015-05-28
Abstract: This disclosure relates to peptide products, uses of the same for the preparation of medicaments for use in the treatment of a condition associated with insulin resistance, diabetes, metabolic syndrome, obesity or cardiovascular disease, the peptides comprising the amino acid sequences of SEQ ID NOS. 1117-1122 and/or 1102-1107. The peptides of the disclosure are modified to have a glycoside surfactant group attached.
Patent NZ-727715-A (NZ)
Title: Novel heterocyclic compounds having prs enzyme inhibitory effect
Inventor: PARK JOON SEOK
IPC: C07D401/12
Filed: 2015-06-23
Abstract: The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.
Patent NZ-730771-A (NZ)
Title: Aurora a kinase inhibitor
Inventor: HENRY JAMES ROBERT
IPC: C07D401/14
Filed: 2015-11-06
Abstract: The present invention provides an aminopyridine compound selected from the group consisting of:(2S,4S)-1-[(3-chloro-2-fluoro-phenyl)methyl]-4-[[3-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridyl]methyl]-2-methyl-piperidine-4-carboxylic acid and (2R,4R)-1-[(3-chloro-2-fluoro-phenyl)methyl]-4-[[3-fluoro-6- [(5-methyl-1H-pyrazol-3-yl)amino]-2-pyridyl]methyl]-2-methyl-piperidine-4-carboxylic acid or a pharmaceutically acceptable salt thereof, that inhibits Aurora A and, therefore may be useful in treating cancer.
Patent NZ-738046-A (NZ)
Title: Delivery of respiratory therapy
Inventor: VELISS LEE JAMES
IPC: A61M16/06
Filed: 2007-07-27
Abstract: A patient interface (10) comprising: a sealing arrangement (20) to seal with or around the patient’s nose; an inlet conduit arrangement (30) including two conduit portions configured to each extend along a respective side of the patient’s face between the patient’s eye and ear, and converging at a top of the patient’s head in use, a connector (32) constructed and arranged to interconnect the inlet conduit arrangement with an air delivery tube, the connector being configured to in use be positioned at the top of the patient’s head, and an adjustable rear strap (46) disposed between the two conduit portions but not in fluid communication therewith, the rear strap being adapted to extend across a rear of the patient’s head. The connector includes a base portion (34) and an inlet tube portion (36) that swivels relative to the base portion. Each conduit portion has a cross-section at a first location along a length of the conduit portion that is different from a cross-section at a second location along the length of the conduit portion.
Patent NZ-742760-A (NZ)
Title: Information processing device, solid object modeling system, information processing method, information processing program and computer-readable recording medium
Inventor: YANG FEI
IPC: G06F17/50
Filed: 2016-11-30
Abstract: In additive manufacturing, toolpath data representing a path and width of the toolpath that indicates a location where the filament is to be discharged with a single stroke is generated, and a 3D model is created by depositing a filament based on the generated toolpath data. In creating the 3D model, if an amount of discharge of a filament per unit of time is constant, a gap, in which a filament is not filled, may occur on a surface of the 3D model or inside the 3D model. In order to address the above problem, the invention aims to work such that when creating a 3D model by discharging filamentary molding materials on a flat surface, making a gap which may occur between the filamentary molding materials discharged on the flat surface small, or preferably eliminating the gap. An aspect of the present invention may be said to broadly subsist in an information processing device for processing three-dimensional information representing a three-dimensional shape of a solid object to be modeled by a solid object modeling device configured to model the solid object by depositing a plurality of layers each of which is formed by discharging the filamentary molding material on the flat surface. The information processing device is configured to acquire the three-dimensional information, generate a plurality of pieces of layer information corresponding to the respective layers of the filamentary molding materials, by slicing the three-dimensional information, generate deposition information used for depositing the filamentary molding material from the layer information, generate gap region information representing a gap region to be formed between the filamentary molding materials based on the deposition information, and generate discharging information for controlling discharge of the filamentary molding material, in accordance with the deposition information and the gap region information, wherein the gap region information generating unit is configured to obtain, from at least one of a plurality of the gap region information, threshold gap region information related to a gap region having a size not less than a predetermined threshold, and based on the threshold gap region information, with respect to the gap region having the size not less than the predetermined threshold, the discharging information generating unit is configured to generate the discharging information including information for controlling a width of the filamentary molding material when the filamentary molding material is deposited on the flat surface, such that a size of the gap region to be formed between the filamentary molding materials is reduced.
Patent NZ-747015-A (NZ)
Title: Active compound combinations comprising carboxamide derivatives and a biological control agent
Inventor: CRISTAU PIERRE
IPC: C12N1/20
Filed: 2013-10-17
Abstract: The present invention relates to active compound combinations, in particular within a composition, which comprises (A) N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, or an agrochemically acceptable salt thereof, and (B) at least Bacillus subtilis strain QST713/AQ713. Moreover, the invention relates to a method for curatively or preventively controlling the phytopathogenic fungi of plants or crops, and to the use of a combination according to the invention for the treatment of plants or corps, including treating seeds.
Patent NZ-761601-A (NZ)
Title: A modular building system
Inventor: WILSON PAUL
IPC: E04B1/14
Filed: 2018-08-23
Abstract: This invention relates to a versatile, modular building system for constructing a building frame. The components of the modular system are formed from high-density materials, and include one or more floor units, a plurality of end units, the end units connected to the floor units, at least one front beam unit, the front beam unit adapted to connect to at least two end units, and one or more front panel units, the front panel unit adapted to connect to at least two end units and/or at least one floor unit. Also described are various additional modular units that may be incorporated into the modular building system described. The modular system is designed to be pre-fabricated off site and quickly erected on building sites with a range of contours.
Patent NZ-765590-A (NZ)
Title: Diaryl substituted 5,5-fused ring compounds as c5ar inhibitors
Inventor: ZENG YIBIN
IPC: C07D231/56
Filed: 2018-12-20
Abstract: The present disclosure provides, inter alia, Compounds of Formula (I) or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.
Patent NZ-784460-A (NZ)
Title: Composition, production method, and usage
Inventor: FUJII KENGO
IPC: A23L33/135
Filed: 2020-03-19
Abstract: Provided are: a composition that includes bacterium powder and fatty oil and has suppressed caking of the bacterium powder; a production method; and a usage.　A composition including bacterium powder, fatty oil, and at least one type selected from the group consisting of a micro-powder and a surfactant; a production method therefor; and a usage as an anti-caking agent for bacterium powder, in at least one type of composition that includes fatty oil and is selected from the group consisting of a micro-powder and a surfactant.
Patent PT-101734-A (PT)
Inventor: LATTER VICTORIA SUSAN
IPC: C07C229/60
Filed: 1995-07-06
Abstract: The present invention relates to the use of known and novel naphthoquinones in the treatment and prophylaxis of Pneumocystis carinii infections, and for the manufacture of medicaments for the treatment and prophylaxis of P.carinii infections, novel formulations containing said compounds, and novel naphthoquinones of formula (VI):   <CHEM>  wherein R<1><1> and R<1><2> each represent =O and the dotted line represents a double bond between the 2 and 3 positions of the quinone ring, in which case R<1><3> represents a group - OCOR5; a group OR<6> or SR<6>; or a group NR<7>R<8>; or the dotted line represents double bonds at the 1,2 and 3,4 positions of the quinol ring and R<1><1>, R<1><2> and R<1><3> each represents a group -OCOR<1><4>, wherein R<1><4> represents an optionally substituted C1-10alkyl group.
Patent PT-103553-A (PT)
Title: Método de redução e controlo ds tensões envolvidas na colapsibilidade de uma embalagem totalmente colapsável
Inventor: VARGAS LUIS
IPC: B65D5/36
Filed: 2006-08-17
Abstract: O ESTADO DA TÉCNICA EM MATÉRIA DE EMBALAGENS PLÁSTICAS QUE SEJAM TOTALMENTE COLAPSÁVEIS, APRESENTA UMA SOLUÇÃO TECNICAMENTE VIÁVEL PARA QUE UMA EMBALAGEM SEJA CAPAZ DE ESPALMAR UMA ÚNICA VEZ. QUANDO A EMBALAGEM É RECONFIGURADA NA SUA FORMA INICIAL, OCORREM DEFORMAÇÕES E RUPTURAS NO MATERIAL QUE COMPROMETEM A SUA CAPACIDADE DE CONTER O PRODUTO, BEM COMO OUTROS REQUISITOS INTRÍNSECOS À SUA FUNÇÃO. AS REFERIDAS ROTURAS E DEFORMAÇÕES SÃO PROVOCADAS PELO EXCESSO DE MATERIAL QUE OCORRE QUANDO UMA EMBALAGEM TOTALMENTE COLAPSÁVEL PASSA DE UM ESTADO INSUFLADO PARA UM ESTADO ESPALMADO, E VICE-VERSA. A PRESENTE INVENÇÃO APRESENTA QUATRO MÉTODOS DE REDUÇÃO E CONTROLO DAS TENSÕES ENVOLVIDAS NA COLAPSIBILIDADE DE UMA EMBALAGEM TOTALMENTE COLAPSÁVEL (1), (4), (7) E (10) AO VIABILIZAR A SUA RE-OPERACIONALIDADE, POSSIBILITA A OPTIMIZAÇÃO DOS PROCESSOS LOGÍSTICOS NO TRANSPORTE E NO ARMAZENAMENTO, AO LONGO DE TODO O CICLO DE VIDA DA EMBALAGEM.
Patent RU-94006234-A (RU)
Inventor: NABOK A A
IPC: F42D5/00
Filed: 1994-02-15
Abstract: FIELD: blasting tests of materials and products. SUBSTANCE: in the armored chamber, girdled by external piping 3 one of walls 1 is made as a truncated conical shell, whose smaller base is connected through valve 5 to one end of piping 3, and the larger base through body wall 2 is connected to the other end of piping 3. EFFECT: enhanced efficiency of blast working.